BB-Cl-Amidine as a novel therapeutic for canine and feline mammary cancer via activation of the endoplasmic reticulum stress pathway

Overview of attention for article published in BMC Cancer, April 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 51 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 28,498 followers.

RT @Morris_Animal: @Morris_Animal Foundation-funded researchers @Cornell study new treatment for breast #cancer in #cats and #dogs. https:/…

22 Jun 2018

Reply Repost Favourite

RT @Morris_Animal: @Morris_Animal Foundation-funded researchers @Cornell study new treatment for breast #cancer in #cats and #dogs. https:/…

13 Jun 2018

Reply Repost Favourite

@Morris_Animal Foundation-funded researchers @Cornell study new treatment for breast #cancer in #cats and #dogs. https://t.co/BvRotImvoE #MAFstudy #mammarycancer https://t.co/OjbAQhLY7R

13 Jun 2018

Reply Repost Favourite

mouse xenograft models will be useful for the study of mammary cancer in dogs and cats, and furthermore, that BB-Cl-Amidine has potential as a novel therapeutic for #mammary_cancer in these species https://t.co/nN1EieoZUu https://t.co/I7pECzuAjH

20 Apr 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.